Results 151 to 160 of about 81,668 (249)

Detrimental Effect of Low‐Magnitude High‐Frequency Vibration in an Ex Vivo Model of Intervertebral Disc Degeneration Despite Estrogen Treatment

open access: yesJOR SPINE, Volume 9, Issue 2, June 2026.
Low‐magnitude high‐frequency vibration (LMHFV), with or without 17β‐oestradiol (E2), exacerbated papain‐induced bovine intervertebral disc degeneration, reducing cell viability, impairing matrix production, and increasing inflammation. E2 showed no protective effect against papain‐induced degeneration or LMHFV.
Jan Ulrich Jansen   +9 more
wiley   +1 more source

Romosozumab and Denosumab Combination Therapy After Denosumab in Postmenopausal Osteoporosis

open access: yesArthritis &Rheumatology, Volume 78, Issue 5, Page 1176-1183, May 2026.
Objective Transition from long‐term denosumab (Dmab) to parathyroid hormone‐analogs or romosozumab (Romo) might expose patients to the risk of the so‐called rebound phenomenon. Adding Romo to Dmab might represent an option in patients experiencing a fracture while on Dmab.
Giovanni Adami   +10 more
wiley   +1 more source

Natural Products as the Modulators of Gut Microbiota: A Pool for the Development of New Treatment Against Obesity?

open access: yesFood Frontiers, Volume 7, Issue 3, May 2026.
Natural compounds regulate gut microbiota by improving microbial balance and increasing probiotics, which boost short‐chain fatty acid production to alleviate insulin resistance and inflammation. Additionally, they stimulate appetite‐suppressing hormones through bile acid signaling, while inhibiting pathogenic bacteria to repair intestinal barrier ...
Hongchao Yuan   +7 more
wiley   +1 more source

Egg yolk hydrolysate shows moderate impact on osteoporosis in ovariectomized rats

open access: yesJournal of the Science of Food and Agriculture, Volume 106, Issue 7, Page 4218-4227, May 2026.
Abstract BACKGROUND This study investigated the protective effect of egg yolk hydrolysate (FC) on osteoporosis in ovariectomized (OVX) rats, a well‐established model of postmenopausal bone loss. OVX rats were fed diets supplemented with 0.2% or 1% FC for 13 weeks.
Ilekuttige Priyan Shanura Fernando   +4 more
wiley   +1 more source

Pathophysiology and Molecular Signalling in Osteoporosis: Linking Risk Factors to Bone Loss

open access: yesJournal of Cellular and Molecular Medicine, Volume 30, Issue 9, May 2026.
ABSTRACT Osteoporosis is a prevalent skeletal disorder characterised by progressive reduction in bone mass, microarchitectural deterioration, and increased fracture susceptibility. In India, approximately one‐third of the elderly population is affected by bone‐related disorders, and the global burden of osteoporosis continues to rise.
Pramoda G.   +5 more
wiley   +1 more source

3D morphological analysis of age and sex‐related changes in human cortical bone remodeling spaces using micro‐CT

open access: yesJournal of Anatomy, Volume 248, Issue 5, Page 719-738, May 2026.
This study investigates human cortical bone remodeling space morphology and its relationship with age and sex using micro‐CT imaging. Remodeling space morphology exhibits great inter‐ and intraindividual variation. Its dimensions decrease with increasing age, but do not differ between sexes.
Xuan Wei   +2 more
wiley   +1 more source

Dysregulation of myddosome complex genes its related to alendronate treatment failure in osteoporosis postmenopausal patients. [PDF]

open access: yesGenet Mol Biol
Oliveira BMR   +5 more
europepmc   +1 more source

Knowledge and practices of postmenopausal women regarding vitamin D and osteoporosis. [PDF]

open access: yesRev Bras Ginecol Obstet
Bastos-Silva Y   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy